Some pyridyl-pyrrole compounds were found to have inhibitory activities against p38 MAP kinase. Their activity was much more potent than that of SB203580 that has a similar overall structure but with a different core group, i.e., an imidazole ring. The complex structure modeling was therefore carried out in an attempt to obtain insights into the interactions of the kinase with the pyridyl-pyrrole compounds and SB203580. The resultant complex models revealed that the imidazole and the pyrrole compounds had similar binding modes and that the representative interactions between the enzyme and the ligand moiety (pyridyl or phenyl) were common. For the sulfoxy moiety including the aliphatic tethers attached to a terminal functional group, the amino acid residues interacting with the moiety were elucidated. Lastly, the affinities of the inhibitors were estimated by calculating the score values with the Ludi program and a good correlation between the p38 MAP kinase inhibitory activities and the score values was found.
Introduction
Mitogen-activated protein (MAP) kinases are important molecules in intracellular signal-transduction pathways that become activated in response to hormones, cytokines, environmental stresses, and other extracellular stimuli. MAP kinases are activated by phosphorylation on Thr and Tyr in a TXY motif, by the upstream MAP kinase kinase [1] [2] . The inhibitors of p38 MAP kinase can reduce the host inflammatory response and may prove efficacious towards disease states such as rheumatoid arthritis [3] [4] [5] .
Several crystal structures of p38 MAP kinase have been determined by X-ray crystallography. The enzyme has two domains that consist of a small N-terminal lobe largely composed of an anti-parallel β-sheet, and a large C-terminal lobe which is mostly α-helical. The ATP cofactor binds in a cleft between the two lobes. Several pyridyl-imidazoles, such as SB203580, are known to inhibit p38 MAP kinase by binding in the ATP pocket [6] . X-ray crystallographic studies revealed that the pyridyl nitrogen atom mimics the N-1 nitrogen of the adenine ring of ATP.
Some pyridyl-pyrrole compounds (3-6) were found to have inhibitory activities against p38 MAP kinase ( Figure 1 ). SB203580 (2) has a similar overall structure but with a different core group, i.e., an imidazole ring. In comparison with SB203580, a pyridyl-imidazole compound with IC 50 values of 0.254 µM, the pyridyl-pyrrole compounds showed very potent activities with IC 50 values of 0.007~0.054 µM. A complex structure modeling was, therefore, carried out in order to analyze the interactions of the inhibitors with p38 MAP kinase.
Futhermore, a correlation between the inhibitory activities and score values calculated by the Ludi program [7] was investigated. The score value was reported to correspond to the dissociation constant K i by Böhm et al [8] [9] . They derived the empirical parameters of the score function from the protein-ligand complexes of known 3D structure in the Protein Data Bank [10] . In this study, two kinds of score functions were used, i.e., score1 and score2, to calculate the score values of inhibitors complexed with p38 MAP kinase. Score1 and score2 were derived from 45 and 82 complexes, respectively [8] [9] . 
Methods
Molecular mechanics calculations with an all-atom force field were performed using the QUANTA/CHARMm system [11] with the supplied parameter set, except for the changes noted. A distance-dependent dielectric constant of 4r was used. The Adopted-Basis Newton Raphson algorithm [12] was employed for the minimization in molecular mechanics calculations with an energy gradient tolerance of 0.01 kcal•mol -1 •Å -1 . The partial atomic charges of the azide structure were derived from quantum mechanics calculations with the Spartan program [13] . A single-point ab initio calculation was carried out with a 6-31G** basis set using the Hartee-Fock theory to obtain the electrostatic potential charges ( . The stereochemistry of the compounds was taken into account by equating the sulfur atom of the sulfoxy group to a chiral carbon atom and the two stereo isomers, R' and S', were considered.
Among the X-ray structures of p38 MAP kinase (1IAN [14] , 1WFC [15] , 1P38 [16] , among others), 1P38 was employed in the modeling for the following reasons. 1IAN forms a complex structure with 1 but only the Cα atom coordinates are known for the protein structure. 1WFC is a human p38, but the coordinates of the activation (phosphorylation) loop are missing. Although 1P38 is a murine p38, only a few of its residues differ from the human p38. It is an apo-enzyme without an inhibitor but all of its atomic coordinates are available. In the preparation of the 3D structure model for the calculation, the His, Asn and Gln side chains were initially analyzed using the Guess_NOHQ program [17] . Their side chain orientations were corrected when they were in the reverse orientation and suitable protonation forms of the imidazole ring were determined. With respect to the binding site, the side chain conformations were modeled in reference to a magnified figure of the binding site with the side chain structures as shown in the literature [14] .
By superposing 1P38 on 1IAN (the complex structure of p38 with 1), the initial position of SB203580 (2) was determined. First, only the inhibitor was optimized while keeping the kinase atoms fixed. Next, the hydrogens within 11Å from the inhibitor were optimized. The complex structure was finally geometry-optimized without restricting the protein side chains within 11Å from the inhibitor. As for 2, two tautomers with different protonation forms for the imidazole ring were built.
In the case of the pyrrole derivatives (3-6), the initial positions of the pyrrole compounds were determined in the same way as 2. With respect to 5 and 6, a systematic conformational search (Grid Scan) in the ligand binding site was carried out by rotating the torsional angles of the sulfoxy moiety -SOR (the sulfoxy group with an aliphatic tether attached to a terminal functional group). The torsional angles of the initial structures are shown in Figure 2 . First, only the inhibitor was optimized while keeping the kinase atoms fixed. Among the resulting stable conformations, those with ∆E<2.5kcal/mol were selected. For each of the selected conformations, the geometry of the inhibitor was optimized by energy-minimization, by including first, hydrogen atoms of the kinase within 11Å from the inhibitor, and then, the side chain atoms of the residues within 11Å from the inhibitor.
The score values, which are the empirical estimates of binding affinities of ligands with proteins, were calculated with the Ludi program. Based on the relationship between the score value and the dissocation constant K i reported in the program manual, K i values of the inhibitors were calculated. A p38 MAP kinase assay was performed by incubating the test compound with 4.92 µg/ml p38 MAP kinase (Upstate Biotechnology, Lake Placid, NY), 66.7 µg/ml ATF-2, and 200 µM ATP in kinase buffer (25 mM Tris, 5 mM β-Glycelphosphate,2 mM dithiothreitol, 0.1 mM Na 3 VO 4 ,10 mM MgCl 2 ) for 30 min at 30°C. The kinase reaction was stopped by the addition of SDS-sample buffer and boiling for 5 min. After SDS-PAGE, phosphorylated ATF-2 was detected by Western blotting using an anti-phosphorylated ATF-2 antibody, HRP-conjugated anti-rabbit secondary antibody, and LumiGLO ® reagent (Cell Signaling Technology, Inc., Beverly, MA) according to the manufacturer's instruction. The inhibitory effect of the test compound against p38 MAP kinase was calculated by quantifying phosphorylated ATF-2 using the ARGUS-20 system (Hamamatsu Photonics K. K., Shizuoka, Japan). 
Results and Discussion

Complex structure
The complex structure of two tautomers of SB203580 (2) revealed that both tautomers had almost identical binding modes and the same conformation energy. Therefore, which tautomer was preferable could not be specified by the calculations. The complex structure model of 2 was compared with the complex crystal structure of a similar compound, 1, which was used for the initial positioning of the ligands in the modeling. Compound 2 differs from 1 only in its 4'-fluoro group. Since only the coordinates of the Cα atom were available for the complex structure of 1, its binding mode reported in the literature was used for the comparison.
According to the literature, the following interactions were observed in the complex structure of 1: a hydrogen bond between the backbone NH of Met109 and the N atom of the pyridine ring, and hydrophobic interactions between residues such as Leu104 and Leu75 and the iodo-phenyl ring, between the methyl group of Thr106 and two aromatic moieties and between the benzene rings of Tyr35 and -PhSOMe of 1. Although the position of the halogens on the benzene ring were different, the modeled complex structure of 2 well-reproduced the binding mode of 1 except for the hydrophobic interaction between the benzene ring of -PhSOMe and that of Tyr35. This interaction was not observed in the modeled structure probably because the complex structure modeling was The complex structure model of the compounds with the pyrrole ring was similar to that of SB203580 (2) in the binding mode, in that the representative interactions were conserved: the hydrogen bonding of the nitrogen atom of the pyridine ring with the backbone NH of Met109 and the hydrophobic interactions between residues such as Leu104 and Leu75 and the fluoro-phenyl ring as well as those between the methyl group of Thr106 and two aromatic moieties of the pyridine ring and the fluoro-phenyl ring.
Since the absolute configurations of the two isomers of 3 and 4 have not been determined yet, they were temporarily defined as R' and S', respectively. After comparing the interaction energy of these two compounds, the difference was small (∆E=~1 kcal/mol) and so, the exact stereochemistry of the compound with the more potent activity could not be specified.
From the stable complex structures obtained for 5 and 6, it was found that there were two main binding sites for the -SOR group. Stereofigures and schematic drawings of the two representative structure models of 6 in the two binding sites are shown in Figures 3 and 4 , respectively. The specific binding interactions are described below. The oxygen atom of -SOR formed hydrogen bonds with the side chain of residues such as Arg173 or Lys152. The electrostatic interaction was observed between the azide group and the residue (Asp150, Ser154 or Lys152) in each site. With respect to 5, a hydrogen bond was also observed between the oxygen atom of -SOR and the side chain of Lys152, Ser154 or Asn155 ( Figure 5 ). The nitro group was hydrogen-bonded with one of the kinase residues (Lys152, Ser154 or Thr185). Further studies using site-directed mutations or X-ray crystallographic analysis will be required to validate the binding modes described above. Nevertheless, these insights may be useful for a b selecting the mutation sites. In addition to the residues mentioned above, neighboring residues that could be involved in the specific interactions of a larger -SOR group were elucidated by the complex structure modeling as shown in Figure 4 . These include Asn114 and Thr175 whose polar side chains might form hydrogen bonds, as well as Ala184 which might be involved in hydrophobic interactions. Although the complex structures presented here are not definite, we consider that these findings may contribute to the structure modifications of new inhibitors. 
Score calculation
The scoring of docked ligands is an important and challenging issue in docking study. It is commonly observed that the calculated interaction energies exhibit poor correlation with the measured affinities of the compounds [18] since the entropic and solvation contributions, which are difficult to evaluate, are not always considered. Recently empirical and knowledge-based scoring functions have been developed. Böhm et al reported that the score value calculated by the Ludi program well approximated the binding affinity [8, 9] . In one of their studies, a correlation with a standard deviation of 1.7 kcal/mol (number of structures = 82, correlation coefficient = 0.89) was obtained between the experimental and calculated binding free energies derived from K i values. We were therefore interested in how the Böhm's score correlated with observed inhibitory activities in our modeled system. The score values were calculated for the conformations obtained by the modeling and the highest score value for each compound is listed in Table 1 . It was shown that the higher the score value is, the more potent the binding affinity is. With respect to score1, score values corresponded well with the order of inhibitory potencies. In other words, the inhibitory activities became higher from compound 2 to 6 as the corresponding values for score1 increased. A similar trend was seen with the values of score2 except for compounds 4 and 5. As the inhibitory activities of 4 and 5 were almost the same, both score1 and score2 were considered to afford good correlations. Based on the equation (score = -100 log K i ), dissociation constants K i were calculated and shown in Table 1 as K i -1 and K i -2 for score1 and score2, respectively. Although the calculated K i values were much larger than the IC 50 values, the relative values had good correlation with the inihibitory activities. The following correlation equations 1 and 2 were obtained for K i -1 and K i -2, respectively:
IC 50 = -0.010 + 0.0071 × K i -1 (r = 0.99)  (1) IC 50 = -0.096 + 0.0032 × K i -2 (r = 0.99)  (2) Generally, in the case of competitive inhibition, the actual K i value is not always identical to the IC 50 [19] . Nevertheless, the predicted score values might have been underestimated. This underestimation might be due to the fact that a hydrophobic interaction between the benzene ring of the -PhSO group and Tyr35 was not observed in every complex model.
Conclusion
We have carried out the complex structure modeling of the p38 MAP kinase with pyridyl-pyrrole compounds and SB203580. The resultant complex models revealed that the imidazole and the pyrrole compounds had similar binding modes and that the representative interactions between the enzyme and the ligand moiety were common. For the sulfoxy moiety with the terminal functional group, the amino acid residues interacting with the moiety were elucidated. Lastly, the affinities of the inhibitors were estimated by calculating the score values and a good correlation between the p38 MAP kinase inhibitory activities and the score values was observed.
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